Clinical implications of REST and TUBB3 in ovarian cancer and its relationship to paclitaxel resistance

Author： Gao Song  

Publisher： Springer Publishing Company

ISSN： 1010-4283

Source： Tumor Biology, Vol.33, Iss.5, 2012-10, pp. : 1759-1765

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acquisition of paclitaxel resistance via PI3Kdependent epithelialmesenchymal transition in A2780 human ovarian cancer cells

By                            

Oncology Reports, Vol. 30, Iss. 3, 2013-01 ,pp. : 1113-1118

Spandidos Publications

Access to resources Recommend Favorite

Increased paclitaxel resistance in recurrent epithelial ovarian cancer: analysis of metachronous tumors

By Matsuo Koji   Im Dwight   Rosenshein Neil  

International Journal of Clinical Oncology, Vol. 15, Iss. 3, 2010-06 ,pp. : 325-327

Springer Publishing Company

Access to resources Recommend Favorite

Hereditary Ovarian Cancer: Molecular Genetics and Clinical Implications

By Boyd J.   Rubin S.C.  

Gynecologic Oncology, Vol. 64, Iss. 2, 1997-02 ,pp. : 196-206

Elsevier

Access to resources Recommend Favorite

Overexpression of heparanase in ovarian cancer and its clinical significance

By Zhang Wei   Chan Hong   Wei Louwei   Pan Zhongmian   Zhang Jieqing   Li Li  

Oncology Reports, Vol. 30, Iss. 5, 2013-11 ,pp. : 2279-2287

Spandidos Publications

Access to resources Recommend Favorite

A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell properties

By                            

Oncology Letters, Vol. 6, Iss. 5, 2013-01 ,pp. : 1295-1298

Spandidos Publications

Access to resources Recommend Favorite